Galderma Raises 2026 Sales Forecast Amid Strong Demand
The company now anticipates higher annual growth as demand for its aesthetic and dermatology products continues to rise.
Updated on Oct. 26, 2026 in Beauty
Live Poll
Do you trust that rising corporate profits in the beauty sector reflect healthy market growth?
Galderma reported a 25.1% increase in net sales to US$4.77 billion for the first nine months of 2026. This growth, including a 26% boost in the third quarter, has led the company to raise its full-year sales forecast for consumers of its dermatology and aesthetic products.
Why it matters
The company adjusted its growth expectations upward due to sustained demand for medical dermatology treatments and skin-care products. This shift reflects broader trends in how patients and providers are accessing dermatological care and aesthetic procedures.
Galderma reports a 25.1% increase in net sales for the first nine months of 2026, supported by 26% growth in the third quarter. While therapeutic dermatology surged 64.4%, the long-term consistency of these growth rates remains under evaluation.
The players
Galderma
A Swiss-based pharmaceutical company specializing in therapeutic dermatology, injectable aesthetics, and dermatological skincare treatments.
The details
The performance gains are driven primarily by the therapeutic dermatology division and a steady uptake in injectable aesthetics and dermatological skincare. Increased interest in products like Nemluvio, which serves specific therapeutic dermatological needs, significantly bolstered the company's financial output. These figures demonstrate a high volume of demand across multiple segments of the skin-health market.
Timeline
First nine months of 2026: Net sales increased 25.1% to US$4.77 billion.
Q3 2026: Sales growth reached 26%.
Full-year 2026: Projected sales growth is 22.5-23.5%.
Health Landscape
This performance aligns with the 2026 global demand for dermatological and aesthetic interventions, which has seen consistent expansion across medical and cosmetic sectors. Galderma’s trajectory marks a significant escalation in the commercialization of therapeutic skin health solutions.
As new therapeutic dermatology options become more widely adopted, patients should discuss potential treatment pathways with their dermatologist. Understanding which products are available for specific skin conditions remains a key component of navigating modern dermatological care.
The takeaway
The increasing availability of therapeutic dermatology products highlights the importance of staying informed about evolving treatment options. When considering new aesthetic or therapeutic skin procedures, always consult your physician to determine if these interventions are appropriate for your health needs.
Further reading
For more on the latest trends in professional skin care, visit Beauty.
Source note: This article includes information reported by Global Cosmetics News.
Live Poll
Do you trust that rising corporate profits in the beauty sector reflect healthy market growth?
